Back to search
FDAFDA · Food and drugs·Recall number D-0097-2023

Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,

Published January 11, 2023 · Recall initiated: December 29, 2022

Summary

FDA records drug Class II recall D-0097-2023, published January 11, 2023 and initiated December 29, 2022. Recalling firm: Pfizer Inc.; Status: Completed; Reported quantity: 62,088 bags; Lot: Lot: 5935283, Exp. 12/01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Bags have the potential to leak.

What to do

Voluntary: Firm initiated · Letter

Get an email if HEPARIN SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HEPARIN SODIUM
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA.
Lot
Lot: 5935283, Exp. 12/01/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA, recalled?

Yes. FDA published recall D-0097-2023 on January 11, 2023. Reported hazard: Lack of assurance of sterility: Bags have the potential to leak.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HEPARIN SODIUM.